口服米诺地尔在斑秃治疗中的应用

doi:10.35541/cjd.20240626

Abstract

Abstract: 【Abstract】 Oral minoxidil has been used to treat various hair loss disorders, including alopecia areata, though its efficacy as a monotherapy remains unclear. In recent years, oral minoxidil has increasingly been applied as an adjuvant treatment alongside other agents such as Janus kinase inhibitors for alopecia areata. This review summarizes the current application of oral minoxidil in the treatment of alopecia areata.

Key words: Alopecia areata, Minoxidil, Oral administration, Therapy, Efficacy, Safety

Wang Qin, Lin Jinran, Liu Qingmei, Wu Wenyu, . Oral minoxidil in the treatment of alopecia areata[J]. Chinese Journal of Dermatology, 2025, 58(7): 653-656.doi:10.35541/cjd.20240626

References ［31］

［1］	Dainichi T, Iwata M, Kaku Y. Alopecia areata: what's new in the epidemiology, comorbidities, and pathogenesis?［J］. J Dermatol Sci, 2023,112（3）:120⁃127. doi: 10.1016/j.jdermsci.2023.09.008.
［2］	Waśkiel⁃Burnat A, Kołodziejak M, Sikora M, et al. Therapeutic management in paediatric alopecia areata: a systematic review［J］. J Eur Acad Dermatol Venereol, 2021,35（6）:1299⁃1308. doi: 10.1111/jdv.17187.
［3］	丁雨薇, 乔建军, 方红. 小分子靶向药物和生物制剂治疗斑秃的研究进展［J］. 中华皮肤科杂志, 2022,55（12）:1118⁃1121. doi: 10.35541/cjd.20200563.
［4］	Nakamura K, Kamei K, Austin J, et al. Degree of alignment between Japanese patients and physicians on alopecia areata disease severity and treatment satisfaction: a real⁃world survey［J］. Dermatol Ther （Heidelb）, 2024,14（1）:151⁃167. doi: 10. 1007/s13555⁃023⁃01067⁃y.
［5］	King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata［J］. J Am Acad Dermatol, 2023,89（2S）:S29⁃S32. doi: 10.1016/j.jaad.2023.05.049.
［6］	Wei D, Chen Y, Shen Y, et al. Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta⁃analysis［J］. Front Immunol, 2023,14:1152513. doi: 10.3389/fimmu.2023.1152513.
［7］	Heymann WR. Coming full circle （almost）: low dose oral minoxidil for alopecia［J］. J Am Acad Dermatol, 2021,84（3）:613⁃614. doi: 10.1016/j.jaad.2020.12.053.
［8］	Fiedler⁃Weiss VC, Rumsfield J, Buys CM, et al. Evaluation of oral minoxidil in the treatment of alopecia areata［J］. Arch Dermatol, 1987,123（11）:1488⁃1490.
［9］	Fiedler VC, Buys CM. Direct T⁃cell effects of minoxidil［J］. Clin Dermatol, 1988,6（4）:148⁃151. doi: 10.1016/0738⁃081x（88）90079⁃x.
［10］	Rudnicka L, Arenbergerova M, Grimalt R, et al. European expert consensus statement on the systemic treatment of alopecia areata［J］. J Eur Acad Dermatol Venereol, 2024,38（4）:687⁃694. doi: 10.1111/jdv.19768.
［11］	Moussa A, Eisman S, Kazmi A, et al. Treatment of moderate⁃to⁃severe alopecia areata in adolescents with baricitinib: a retrospective review of 29 patients［J］. J Am Acad Dermatol, 2023,88（5）:1194⁃1196. doi: 10.1016/j.jaad.2022.12.033.
［12］	Valido K, Craiglow BG. Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients［J］. J Am Acad Dermatol, 2025:S0190⁃9622（25）00565⁃00561. doi: 10.1016/j.jaad.2025.03.085.
［13］	Jerjen R, Meah N, Trindade de Carvalho L, et al. Treatment of alopecia areata in pre⁃adolescent children with oral tofacitinib: a retrospective study［J］. Pediatr Dermatol, 2021,38（1）:103⁃108. doi: 10.1111/pde.14422.
［14］	Sanchez⁃Diaz M, Diaz⁃Calvillo P, Rodriguez⁃Pozo JA, et al. Tofacitinib for treatment of alopecia areata: real⁃world evidence and factors associated with therapeutic response［J］. Acta Derm Venereol, 2022,102:adv00736. doi: 10.2340/actadv.v102.2036.
［15］	Wambier CG, Craiglow BG, King BA. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata［J］. J Am Acad Dermatol, 2021,85（3）:743⁃745. doi: 10.1016/j.jaad.2019. 08.080.
［16］	Moussa A, Bokhari L, Sinclair RD. Systemic minoxidil as maintenance treatment in alopecia areata: a retrospective case series of 24 patients［J］. Clin Exp Dermatol, 2022,47（4）:753⁃755. doi: 10.1111/ced.15051.
［17］	Vañó⁃Galván S, Pirmez R, Hermosa⁃Gelbard A, et al. Safety of low⁃dose oral minoxidil for hair loss: a multicenter study of 1404 patients［J］. J Am Acad Dermatol, 2021,84（6）:1644⁃1651. doi: 10.1016/j.jaad.2021.02.054.
［18］	Darchini⁃Maragheh E, Rees H, Moussa A, et al. Role of systemic minoxidil in the treatment of alopecia areata: a scoping review to direct future research［J］. J Am Acad Dermatol, 2024,90（6）:1304⁃1306. doi: 10.1016/j.jaad.2024.02.031.
［19］	Jimenez⁃Cauhe J, Saceda⁃Corralo D, Rodrigues⁃Barata R, et al. Characterization and management of hypertrichosis induced by low⁃dose oral minoxidil in the treatment of hair loss［J］. J Am Acad Dermatol, 2021,84（1）:222⁃223. doi: 10.1016/j.jaad. 2020.08.124.
［20］	Moussa A, Kazmi A, Bokhari L, et al. Bicalutamide improves minoxidil⁃induced hypertrichosis in female pattern hair loss: a retrospective review of 35 patients［J］. J Am Acad Dermatol, 2022,87（2）:488⁃490. doi: 10.1016/j.jaad.2021.10.048.
［21］	Nohria A, Desai D, Sikora M, et al. To evaluate hypertrichosis with low dose oral minoxidil and spironolactone combination therapy for alopecia［J］. Arch Dermatol Res, 2024,316（8）:510. doi: 10.1007/s00403⁃024⁃03261⁃0.
［22］	Ong M, Do H, Ho B, et al. Low⁃dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood⁃pressure changes: a retrospective study［J］. J Am Acad Dermatol, 2024,90（2）:425⁃427. doi: 10.1016/j.jaad.2023.10.010.
［23］	Sanabria BD, Palmegiani E, Seron AF, et al. Prospective cardiovascular evaluation with 24⁃hour Holter and 24⁃hour ambulatory blood pressure monitoring in men using 5⁃mg oral minoxidil for androgenetic alopecia［J］. J Am Acad Dermatol, 2023,88（2）:436⁃437. doi: 10.1016/j.jaad.2022.05.026.
［24］	Jimenez⁃Cauhe J, Pirmez R, Müller⁃Ramos P, et al. Safety of low⁃dose oral minoxidil in patients with hypertension and arrhythmia: a multicenter study of 264 patients［J］. Actas Dermosifiliogr, 2024,115（1）:28⁃35. doi: 10.1016/j.ad.2023.07.019.
［25］	John JM, Sinclair R. Safety and tolerability of low⁃dose oral minoxidil in adolescents: a retrospective review［J］. J Am Acad Dermatol, 2023,88（2）:502⁃504. doi: 10.1016/j.jaad.2022.06. 1195.
［26］	Sánchez⁃Díaz M, López⁃Delgado D, Montero⁃Vílchez T, et al. Systemic minoxidil accidental exposure in a paediatric population: a case series study of cutaneous and systemic side effects［J］. J Clin Med, 2021,10（18）:4257. doi: 10.3390/jcm 10184257.
［27］	Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth［J］. Br J Dermatol, 2004,150（2）:186⁃194. doi: 10. 1111/j.1365⁃2133.2004.05785.x.
［28］	Lachgar S, Charveron M, Gall Y, et al. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells［J］. Br J Dermatol, 1998,138（3）:407⁃411. doi: 10.1046/j.1365⁃2133.1998.02115.x.
［29］	Fiedler VC, Buys CM. Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment［J］. Dermatologica, 1987,175（Suppl 2）:29⁃35. doi: 10.1159/000248899.
［30］	Fiedler⁃Weiss VC, Buys CM. Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation［J］. Br J Dermatol, 1987,117（6）:759⁃763. doi: 10.1111/j.1365⁃2133. 1987.tb07357.x.
［31］	Raval RS, Nohria A, Desai D, et al. The use of minoxidil in the treatment of alopecia areata: a systematic review［J］. J Am Acad Dermatol, 2024,91（3）:508⁃509. doi: 10.1016/j.jaad.2024.05.037.

[1]	Wang Qin, Ni Chunya, Yang Kai, Lin Jinran, Wu Wenyu, . Application of low-dose oral minoxidil in the treatment of androgenetic alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 657-660.
[2]	Zhang Li, Song Xiuzu. Role of vascular endothelial growth factor in androgenetic alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 683-685.
[3]	Shao Guanghui, Li Yuqian, Chen Qitao, Zhu Qilin, Zhu Jing, Li Zhongming, Du Xufeng, Fan Weixin. Congenital triangular alopecia [J]. Chinese Journal of Dermatology, 2025, 58(7): 668-671.
[4]	Wei Ran, Li Qinfeng. Novel targeted drugs for the treatment of pediatric alopecia areata [J]. Chinese Journal of Dermatology, 2025, 58(7): 650-653.
[5]	Li Xiangqian, Zhang Jianzhong, Zhou Cheng. Advances in the clinical research on systemic small-molecule drugs and biologics for the treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2025, 58(7): 646-649.
[6]	Sun Jiayi, Song Xiuzu. Autophagy in hair physiology and pathology [J]. Chinese Journal of Dermatology, 2025, 58(7): 679-682.
[7]	Lin Jinran, Leong Hiochon, Liu Qingmei, Wu Wenyu. Androgenetic alopecia and metabolic syndrome: from mechanisms to treatment strategies [J]. Chinese Journal of Dermatology, 2025, 58(7): 591-594.
[8]	Lyu Shuying, Wang Ying, Lin Wenjun, Yang Dingquan. Efficacy of combination therapy with tofacitinib in the treatment of alopecia ophiasis: a retrospective analysis of 21 cases [J]. Chinese Journal of Dermatology, 2025, 58(7): 630-635.
[9]	Hair Research Group, Chinese Society of Dermatology. Chinese expert consensus on the diagnosis and treatment of lichen planopilaris/frontal fibrosing alopecia （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(7): 583-590.
[10]	Li Yu, Wang Ziwei, Ye Rongjia, Li Rong, Zhu Yan, Zhang Xiaohua, Huang Dan, Ju Mei. Home-based phototherapy implementation and management needs in patients with vitiligo: a questionnaire survey analysis [J]. Chinese Journal of Dermatology, 2025, 58(7): 608-612.
[11]	Qi-Quan CHEN Song Zhi-Qiang WANG Gang. Guidelines for the diagnosis and treatment of refractory chronic spontaneous urticaria in China （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(6): 485-496.
[12]	Huang Xuewei, Chen Qiquan, Yang Xianjie, Chen Anqi, Wang Huan, Deng Sisi, Zhai Zhifang, Wang Juan, Song Zhiqiang . Comparisons of clinical and pathological characteristics of urticarial vasculitis versus chronic spontaneous urticaria with pigmentation [J]. Chinese Journal of Dermatology, 2025, 58(6): 508-514.
[13]	Zhao Meiru, Xiao Meng, Zhang Xinmei, Zhang Junyan, Qi Yuqing, Wang Huiping. Omalizumab for the treatment of eight patients with chronic spontaneous urticaria during pregnancy and lactation [J]. Chinese Journal of Dermatology, 2025, 58(6): 536-539.
[14]	Qiu Li, Xiao Ting . Bruton′s tyrosine kinase inhibitors in the treatment of chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2025, 58(6): 563-567.
[15]	Bai Lu, Chu Yan, Liu Yuanyuan, Zhu Caiyong. Treatment of chronic hand eczema [J]. Chinese Journal of Dermatology, 2025, 58(5): 477-480.

Oral minoxidil in the treatment of alopecia areata

PDF

Knowledge

Abstract

Cite this article

share this article

References ［31］

Related Articles 15

Metrics

Comments

Recommended 10